MSFT   214.46 (+0.77%)
FB   243.77 (+0.08%)
GOOGL   1,522.32 (+1.25%)
AMZN   3,129.97 (+1.59%)
NVDA   416.97 (+2.04%)
CGC   16.03 (-1.84%)
AMD   55.83 (+4.49%)
DIS   117.04 (+0.33%)
BAC   22.75 (-1.52%)
MSFT   214.46 (+0.77%)
FB   243.77 (+0.08%)
GOOGL   1,522.32 (+1.25%)
AMZN   3,129.97 (+1.59%)
NVDA   416.97 (+2.04%)
CGC   16.03 (-1.84%)
AMD   55.83 (+4.49%)
DIS   117.04 (+0.33%)
BAC   22.75 (-1.52%)
MSFT   214.46 (+0.77%)
FB   243.77 (+0.08%)
GOOGL   1,522.32 (+1.25%)
AMZN   3,129.97 (+1.59%)
NVDA   416.97 (+2.04%)
CGC   16.03 (-1.84%)
AMD   55.83 (+4.49%)
DIS   117.04 (+0.33%)
BAC   22.75 (-1.52%)
MSFT   214.46 (+0.77%)
FB   243.77 (+0.08%)
GOOGL   1,522.32 (+1.25%)
AMZN   3,129.97 (+1.59%)
NVDA   416.97 (+2.04%)
CGC   16.03 (-1.84%)
AMD   55.83 (+4.49%)
DIS   117.04 (+0.33%)
BAC   22.75 (-1.52%)
Log in

NASDAQ:SIENSientra Stock Price, Forecast & News

$3.96
-0.01 (-0.25 %)
(As of 07/9/2020 10:32 AM ET)
Add
Compare
Today's Range
$3.90
Now: $3.96
$4.00
50-Day Range
$3.39
MA: $4.00
$4.51
52-Week Range
$1.00
Now: $3.96
$9.71
Volume4,521 shs
Average Volume992,918 shs
Market Capitalization$198.12 million
P/E RatioN/A
Dividend YieldN/A
Beta1.51
Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products to plastic surgeons in the United States. It operates through two segments, Breast Products and miraDry. The company offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra, AlloX2, OPUS, Dermaspan, Softspan, and BIOCORNEUM brand names. It also provides body contouring products; facial and nasal implants; saline filled breast implant sizers; and miraDry System, a non-surgical device for the permanent reduction of underarm sweat, odor, and hair of all colors. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Santa Barbara, California.
Read More
Sientra logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.47 out of 5 stars


Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SIEN
CUSIPN/A
Phone805-562-3500

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$83.70 million
Book Value$1.65 per share

Profitability

Net Income$-106,820,000.00
Net Margins-134.87%

Miscellaneous

Employees339
Market Cap$198.12 million
Next Earnings Date8/13/2020 (Estimated)
OptionableOptionable

Receive SIEN News and Ratings via Email

Sign-up to receive the latest news and ratings for SIEN and its competitors with MarketBeat's FREE daily newsletter.

Sientra (NASDAQ:SIEN) Frequently Asked Questions

How has Sientra's stock been impacted by COVID-19 (Coronavirus)?

Sientra's stock was trading at $2.44 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, SIEN stock has increased by 62.3% and is now trading at $3.96. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Sientra?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sientra in the last year. There are currently 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Sientra.

When is Sientra's next earnings date?

Sientra is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020. View our earnings forecast for Sientra.

How were Sientra's earnings last quarter?

Sientra Inc (NASDAQ:SIEN) released its quarterly earnings results on Monday, May, 11th. The medical instruments supplier reported ($0.57) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.49) by $0.08. The medical instruments supplier had revenue of $16.93 million for the quarter, compared to the consensus estimate of $18.70 million. Sientra had a negative net margin of 134.87% and a negative return on equity of 101.94%. View Sientra's earnings history.

What price target have analysts set for SIEN?

6 brokers have issued 12-month target prices for Sientra's shares. Their forecasts range from $5.00 to $9.00. On average, they expect Sientra's stock price to reach $6.46 in the next year. This suggests a possible upside of 63.1% from the stock's current price. View analysts' price targets for Sientra.

Has Sientra been receiving favorable news coverage?

News headlines about SIEN stock have trended negative on Thursday, InfoTrie Sentiment reports. The research group identifies positive and negative news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Sientra earned a media sentiment score of -2.1 on InfoTrie's scale. They also gave news stories about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news about Sientra.

Are investors shorting Sientra?

Sientra saw a decrease in short interest in the month of June. As of June 30th, there was short interest totaling 4,410,000 shares, a decrease of 18.5% from the June 15th total of 5,410,000 shares. Based on an average daily volume of 1,870,000 shares, the days-to-cover ratio is currently 2.4 days. Approximately 10.3% of the company's shares are sold short. View Sientra's Current Options Chain.

Who are some of Sientra's key competitors?

What other stocks do shareholders of Sientra own?

Who are Sientra's key executives?

Sientra's management team includes the following people:
  • Mr. Jeffrey M. Nugent, Chairman & CEO (Age 73, Pay $1.92M)
  • Mr. Paul Sean Little, CFO, Sr. VP & Treasurer (Age 55, Pay $513.65k)
  • Mr. Charles Huiner, Consultant (Age 49, Pay $558.46k)
  • Mr. Keith J. Sullivan, Director & Advisor to MiraDry Bus. (Age 62, Pay $40k)
  • Ms. Deborah Bettencourt, VP of HR & Corp. Admin.

What is Sientra's stock symbol?

Sientra trades on the NASDAQ under the ticker symbol "SIEN."

How do I buy shares of Sientra?

Shares of SIEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Sientra's stock price today?

One share of SIEN stock can currently be purchased for approximately $3.96.

How big of a company is Sientra?

Sientra has a market capitalization of $198.12 million and generates $83.70 million in revenue each year. The medical instruments supplier earns $-106,820,000.00 in net income (profit) each year or ($2.29) on an earnings per share basis. Sientra employs 339 workers across the globe.

What is Sientra's official website?

The official website for Sientra is www.sientra.com.

How can I contact Sientra?

Sientra's mailing address is 420 SOUTH FAIRVIEW AVENUE SUITE 200, SANTA BARBARA CA, 93117. The medical instruments supplier can be reached via phone at 805-562-3500 or via email at [email protected]

This page was last updated on 7/9/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.